PlainRecalls
FDA Devices Moderate Class II Ongoing

Enhanced Verify Evaluation Handset (CFN HH90130FA)

Reported: May 7, 2025 Initiated: April 3, 2025 #Z-1704-2025

Product Description

Enhanced Verify Evaluation Handset (CFN HH90130FA)

Reason for Recall

Evaluation handsets may not be able to communicate with the neurostimulator due to handsets having a faster processing speed than prior handsets. An inability to connect may cause the therapy to stop being delivered and a system error will be displayed. Patient may experience return of underlying disease symptoms (e.g. overactive bladder, urinary retention, or fecal incontinence) based on their response to stimulation during the evaluation period.

Details

Recalling Firm
Medtronic Neuromodulation
Units Affected
534
Distribution
US Nationwide distribution including in the states of AR, AZ, CA, CO, CT, FL, GA, IA, IL, IN, LA, MA, MD, MI, MN, MS, NC, NE, NJ, NM, NY, OH, OR, PA, TX, WA, WI.
Location
Minneapolis, MN

Frequently Asked Questions

What product was recalled?
Enhanced Verify Evaluation Handset (CFN HH90130FA). Recalled by Medtronic Neuromodulation. Units affected: 534.
Why was this product recalled?
Evaluation handsets may not be able to communicate with the neurostimulator due to handsets having a faster processing speed than prior handsets. An inability to connect may cause the therapy to stop being delivered and a system error will be displayed. Patient may experience return of underlying disease symptoms (e.g. overactive bladder, urinary retention, or fecal incontinence) based on their response to stimulation during the evaluation period.
Which agency issued this recall?
This recall was issued by the FDA Devices on May 7, 2025. Severity: Moderate. Recall number: Z-1704-2025.